Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04500548
Title Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston Texas 77030 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792 United States Details
British Columbia Children's Hospital Vancouver British Columbia V6H 3V4 Canada Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field